BioElectronics Corporation Featured At VigilantTrader.com

FREDERICK, Md., July 11 /PRNewswire-FirstCall/ -- BioElectronics Corporation, is pleased to announce the company has been featured at VigilantTrader.com (www.vigilanttrader.com).

BioElectronics Corporation is the maker of ActiPatch(TM), a drug-free anti-inflammatory patch with an embedded battery operated microchip that delivers weeks of continuous pulsed therapy for less than a dollar a day. The unique ActiPatch delivery system, using patented technology, provides a cost- effective, patient friendly method to reduce soft tissue pain and swelling.

Andrew J. Whelan, President of BioElectronics Corporation, stated, “BioElectronics Corporation has made great strides over the past few months, and as we continue to grow it is imperative to share our story with the investment community. Being featured at VigilantTrader.com allows the company to be viewed by investors from all over the world, which will further increase our market awareness.”

About VigilantTrader.com:

VigilantTrader.com (www.vigilanttrader.com) serves as a meeting place for investors and public companies. Vigilant Trader helps investors perform due diligence on the stocks they trade, own, or may be interested in acquiring through the use of their world-class financial site, which offers SEC Filings, Historical Quotes and other financial tools. This serves as the perfect spot for public companies to showcase their unique abilities to the investment community. It supplies public companies with the access and exposure to the investors they seek. This helps raise market awareness and obtain the recognition its companies deserve.

Safe Harbor Statement:

This news release contains forward-looking statements related to future growth and earnings opportunities. Such statements are based upon certain assumptions and assessments made by management of both companies in light of current conditions, expected future developments and other factors it believes to be appropriate. Actual results may differ as a result of factors over which the companies have no control.

BioElectronics Corporation

CONTACT: Andrew J. Whelan, President & CEO or Thomas O’Connor, EVPOperations & COO, both of BioElectronics Corporation, +1-301-644-3906, fax+1-301-644-3939 or info@bioelectronicscorp.com

MORE ON THIS TOPIC